review Open AccessTop 1% cited
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
Annals of the Rheumatic Diseases · 2016 · Vol. 76(3) · pp. 476–485
Laura Andréoli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia)George Βertsias(University of Crete)Nancy Agmon‐Levin(Tel Aviv University)Susan Brown(Royal National Hospital for Rheumatic Diseases)Ricard Cervera(Hospital Clínic de Barcelona)N. Costedoat‐Chalumeau(Délégation Paris 5)Andrea Doria(University of Padua)Rebecca Fischer‐Betz(Düsseldorf University Hospital)Frauke Förger(University Hospital of Bern)Maria Francisca Moraes‐Fontes(Hospital Curry Cabral)Munther A. Khamashta(St Thomas' Hospital)J.J. KingAndrea Lojacono(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia)Francesca MarchioriPier Luigi Meroni(University of Milan)Marta Mosca(University of Pisa)Mario Motta(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia)Monika Østensen(St Olav's University Hospital)Cristina Pamfil(Iuliu Hațieganu University of Medicine and Pharmacy)Luigi Raio(University Hospital of Bern)Matthias Schneider(Düsseldorf University Hospital)Elisabet Svenungsson(Karolinska University Hospital)Maria G. Tektonidou(National and Kapodistrian University of Athens)Şule Yavuz(Istanbul Bilim University)Dimitrios T. Boumpas(National and Kapodistrian University of Athens)Anǵela Tincani✉(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia)
Systemic Lupus Erythematosus ResearchPregnancy and Medication ImpactSystemic Sclerosis and Related DiseasesMedicineAntiphospholipid syndromePregnancyPopulationDiseaseHydroxychloroquinePremature MenopauseObstetricsIntensive care medicineMenopause
MeSH terms
Contraceptives, Oral, HormonalDelphi TechniqueFamily Planning ServicesFemaleFetal MonitoringGenital Neoplasms, FemaleHumansLupus Erythematosus, SystemicMenopausePregnancyPregnancy ComplicationsEstrogen Replacement TherapyAntiphospholipid SyndromePreconception CareRisk Assessment
Citations
875
FWCI
61.37
field-weighted impact
References
176
Percentile
100%
vs. same field & year
Citations per year
Cited by
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Annals of the Rheumatic Diseases · 2023 · 803 citations
2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis
Annals of the Rheumatic Diseases · 2020 · 788 citations
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Annals of the Rheumatic Diseases · 2019 · 1,964 citations
EULAR recommendations for the management of antiphospholipid syndrome in adults
Annals of the Rheumatic Diseases · 2019 · 1,151 citations
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Kidney International · 2021 · 2,277 citations
References
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
Arthritis & Rheumatism · 2002 · 2,137 citations
BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids: Table 1
Lara D. Veeken · 2016 · 418 citations
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
Annals of the Rheumatic Diseases · 2016 · 1,034 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.